Filter
635
Text search:
Serum
Institute
Featured
Recommendations
86
New Publications
181
Language
Document type
No document type
345
Guidelines
137
Studies & Reports
88
Manuals
21
Fact sheets
20
Strategic & Response Plan
14
Situation Updates
5
Training Material
3
Resource Platforms
2
Countries / Regions
India
96
Global
29
South Africa
17
Nigeria
14
Latin America and the Carribbean
13
Western and Central Europe
13
Ethiopia
12
Uganda
12
Kenya
12
Philippines
11
Germany
10
Bangladesh
8
Brazil
8
Nepal
7
Sierra Leone
6
Ghana
6
Zambia
6
Rwanda
6
Namibia
6
West and Central Africa
6
Indonesia
5
Eastern Europe
5
Liberia
4
Tanzania
4
East and Southern Africa
4
Africa
4
Congo, Democratic Republic of
3
USA
3
Pakistan
3
Syria
3
Myanmar / Burma
3
Venezuela
3
Guinea
2
Burkina Faso
2
South Sudan
2
Malawi
2
Mozambique
2
Sudan
2
Angola
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Paraguay
2
Russia
2
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Cameroon
1
Iraq
1
Jordan
1
Lebanon
1
Turkey
1
Chad
1
Cambodia
1
North Macedonia
1
Switzerland
1
Colombia
1
Ecuador
1
Greece
1
Chile
1
Middle East and North Africa
1
Western Pacific Region
1
Asia
1
Bhutan
1
Poland
1
Albania
1
Moldova
1
Iran
1
Uzbekistan
1
Georgia
1
North America
1
Jamaica
1
Denmark
1
Tunisia
1
United Kingdom
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
254
Clinical Guidelines
122
Public Health
38
Women & Child Health
26
Pharmacy & Technologies
20
Key Resources
7
Capacity Building
1
Toolboxes
COVID-19
72
Rapid Response
41
TB
40
NTDs
37
HIV
36
Mental Health
32
NCDs
32
Ebola
15
Pharmacy
14
Caregiver
13
Zika
12
AMR
12
Refugee
11
Planetary Health
9
Global Health Education
6
Specific Hazards
4
Disability
3
Cholera
3
Conflict
3
Polio
2
Natural Hazards
2
Health Financing Toolbox
1
Namibia is no exception to the growingglobal concern on the increasing burden of NCDs. Namibia is an upper middle income country with fast economic growth since independence in 1990. The country is bearing the double burden of communicable and noncommunicable diseases and rapid urbanizat
...
Birth defects surveillance: quick reference handbook of selected congenital anomalies and infections
This Quick Reference Handbook of Selected Congenital Anomalies and Infections is a companion tool to Birth defects surveillance: a manual for programme managers, and is intended for use by front-line health care professionals who are diagnosing and collecting data on congenital defects and infection
...
Available in Arabic, Chinese, English, French, Portuguese and Spanish
https://apps.who.int/iris/handle/10665/334254
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it
...
The World Health Organization’s comprehensive antenatal care (ANC) guideline WHO recommendations on antenatal care for a positive pregnancy experience was first published in 2016 with the objective of improving the quality of routine health care that all women and adolescent girls receive during p
...
High salt consumption is an important determinant of high blood pressure and reducing it would improve health outcomes by lowering cardiovascular disease and therefore death rates. Reducing salt intake has been identified as one of the most effective public health measures and is one of the leading
...
Recommendations for health care professionals – the experience from Latvia
18 Janaury 2021
EU/EEA Member States and the UK have increased their laboratory capacity tremendously over the past 11 months as the majority of the Member States reported sufficient testing capacity until March 2021.
Many countries are adding rapid antigen detection tests (RADT) to their
...
The objectives of pertussis surveillance are to:hmonitor disease burden and the impact of the pertussis vaccination programme, with a special focus on understanding the morbidity and mortality in children < 5 years of agehgenerate data to inform vaccine schedule and delivery strategy decisions to optimize the impact of
...
Änderung gegenüber der Version vom 26.1.2021: Aktualisierung der Informationen über monoklonale Antikörper und Rekonvaleszentenplasma
N Engl J Med 2019;380:2429-39.DOI: 10.1056/NEJMoa1901113
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp
...
WHO list of priority medical devices for management of cardiovascular diseases and diabetes
recommended
This publication was developed in response to the need for a reference list of priority medical devices required for management of noncommunicable diseases (NCDs), focusing on cardiovascular diseases and diabetes, especially for low- and middle-income countries to support universal health coverage a
...
This manual describes methods for investigating clusters or outbreaks that may be of chemical origin and describes the importance of a structured, coordinated, collaborative multidisciplinary, multi-agency approach at local, regional, national and international levels.
